Covalent organic framework-based immunosensor to detect plasma Latexin reveals novel biomarker for coronary artery diseases
Analytica Chimica Acta · 2023
DOI: 10.1016/j.aca.2023.341993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Xiuzhen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine,…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Metal-Organic Frameworks, Metal Nanoparticles, Cardiovascular Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
It is a great challenge to develop an efficient and rapid method to detect of biomarkers of cardiovascular disease. In this research, a differential pulse voltammetry (DPV)-based ultrasensitive immunosensor for the detection of plasma Latexin (LXN) has been established. With the aim to increase the surface area of the bare glassy carbon electrode (GCE), multi-walled carbon nanotube-graphene oxide has been developed. Covalent organic frameworks (COFs) are dropped with gold nanoparticles (AuNPs), secondary antibody and thionine (Thi-Ab2-Au-COFs) act as the signal probe with high electronic conductivity. Under the ideal conditions, the immunosensor displayed a broad linear response range from 0.01 ng mL-1 to 100 ng mL-1, with a detection limit of 50 pg mL-1 (S/N = 3). The immunosensor also demonstrates outstanding sensitivity, repeatability, and stability. Finally, we utilized the designed immunosensor to detect plasma LXN in coronary artery disease (CAD) patients, and the data showed that plasma LXN was significantly increased in CAD patients with a good performance of ROCAUC (AUC 0.871, 95 % CI 0.725-1.0, p = 0.002), indicating plasma LXN is a potential biomarker of cardiovascular disease. This immunosensor is a promising strategy for screening CAD patients in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, Laboratory Animal Center, School of Chemistry and Pharmacy, Guangxi N…
- Department of Cardiology, Dongguan People's Hospital, Southern Medical University, Dongguan, China; Heyuan Research Center for Cardiovascular Diseases, Department of Cardiology, The Fifth Affiliated Hospital of Jinan Un…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Li, X., Wan, H., Tian, Y., Wang, J., Xu, S., Huang, K., Liang, H., & Chen, M. (2023). Covalent organic framework-based immunosensor to detect plasma Latexin reveals novel biomarker for coronary artery diseases. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341993
Vancouver
Li X, Wan H, Tian Y, Wang J, Xu S, Huang K, et al. Covalent organic framework-based immunosensor to detect plasma Latexin reveals novel biomarker for coronary artery diseases. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341993
BibTeX
@article{Li2023,
author = {Li, Xiuzhen and Wan, Huaibin and Tian, Yang and Wang, Jingzhu and Xu, Shaohua and Huang, Kebin and Liang, Hong and Chen, Ming},
title = {Covalent organic framework-based immunosensor to detect plasma Latexin reveals novel biomarker for coronary artery diseases},
journal = {Analytica Chimica Acta},
year = {2023},
doi = {10.1016/j.aca.2023.341993}
}
EUVIMED